The data obtained by in vivo analyses revealed that subcutaneous injection of 5-AMQ in diet-induced obese C57Bl/6 mice caused significant weight loss, reduced adipose tissue mass, improved oral glucose tolerance and insulin sensitivity, and suppressed hyperinsulinemia. The gene discussed is INS; the disease is hyperinsulinism.